Inventor · disambiguated record
Robert Humphreys
Also filed as: HUMPHREYS ROBERT · HUMPHREYS ROBERT E
16 granted patents·9 pending applications·335 citations·filing 1987–2014
94Inventor score
Files withANTIGEN EXPRESS INC13HUMPHREYS ROBERT6UNIV MASSACHUSETTS3GEN ELECTRIC CAPITAL CORP1ROYAL TECHNOLOGY INC1
Top patents by PatentIndex Score
25 records- 0191US7179645B2Ii-Key/antigenic epitope hybrid peptide vaccinesANTIGEN EXPRESS INC·Filed 2002·Granted Feb 20, 2007·54 cites·8 claims
- 0289US8815249B2Ii-key/antigenic epitope hybrid peptide vaccinesHUMPHREYS ROBERT·Filed 2010·Granted Aug 26, 2014·8 cites·8 claims
- 0387US7935350B2Ii-key/Her-2/neu hybrid cancer vaccineANTIGEN EXPRESS INC·Filed 2007·Granted May 3, 2011·4 cites·4 claims
- 0484US4813070ATelephone intercept systemROYAL TECHNOLOGY INC·Filed 1987·Granted Mar 14, 1989·70 cites·35 claims
- 0583US5919639AIi peptide therapeutics to enhance antigen presentationUNIV MASSACHUSETTS·Filed 1997·Granted Jul 6, 1999·40 cites·8 claims
- 0682US7541334B2Hybrid peptides modulate the immune responseANTIGEN EXPRESS INC·Filed 2007·Granted Jun 2, 2009·3 cites·1 claims
- 0780US7774274B2Payment card processing system and methodsGEN ELECTRIC CAPITAL CORP·Filed 2003·Granted Aug 10, 2010·40 cites·20 claims
- 0878US5559028AMethods of enhancing or antigen presentation to T cells inhibitingANTIGEN EXPRESS INC·Filed 1993·Granted Sep 24, 1996·37 cites·3 claims
- 0977US7205274B2Hybrid peptides modulate the immune responseANTIGEN EXPRESS INC·Filed 2002·Granted Apr 17, 2007·6 cites·3 claims
- 1073US9289487B2II-key/antigenic epitope hybrid peptide vaccinesHUMPHREYS ROBERT·Filed 2005·Granted Mar 22, 2016·4 cites·8 claims
- 1173US8889143B2Ii-key/HER-2/neu hybrid cancer vaccineHUMPHREYS ROBERT·Filed 2009·Granted Nov 18, 2014·0 cites·3 claims
- 1271US6432409B1Hybrid peptides modulate the immune responseANTIGEN EXPRESS INC·Filed 1999·Granted Aug 13, 2002·24 cites·6 claims
- 1370US2010255019A1Ii-KEY/HER-2/NEU HYBRID CANCER VACCINEHUMPHREYS ROBERT·Filed 2009·Application pending·0 cites
- 1464US2015093402A1Ii-KEY/HER-2/NEU HYBRID CANCER VACCINEANTIGEN EXPRESS INC·Filed 2014·Application pending·0 cites
- 1562US5726020AInhibition of II synthesisUNIV MASSACHUSETTS·Filed 1996·Granted Mar 10, 1998·23 cites·23 claims
- 1656US6368855B1MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expressionANTIGEN EXPRESS INC·Filed 1998·Granted Apr 9, 2002·11 cites·39 claims
- 1755US2008305122A1Ii-Key/antigenic epitope hybrid peptide vaccinesANTIGEN EXPRESS INC·Filed 2007·Application pending·0 cites
- 1852US5679527AModification of polypeptide structureANTIGEN EXPRESS INC·Filed 1994·Granted Oct 21, 1997·11 cites·1 claims
- 1949US2003235594A1Ii-Key/antigenic epitope hybrid peptide vaccinesANTIGEN EXPRESS INC·Filed 2002·Application pending·0 cites
- 2048US2006008448A1Inhibition of li expression in mammalian cellsXU MINZHEN·Filed 2004·Application pending·0 cites
- 2148US2003198626A1Inhibition of Ii expression in mammalian cellsANTIGEN EXPRESS INC·Filed 2002·Application pending·0 cites
- 2246US2003054365A1MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expressionANTIGEN EXPRESS INC·Filed 2002·Application pending·0 cites
- 2346US2008095798A1Ii-key enhanced vaccine potencyHUMPHREYS ROBERT·Filed 2006·Application pending·0 cites
- 2433US6835382B2Ii peptide therapeutics to enhance antigen presentationUNIV MASSACHUSETTS·Filed 1999·Granted Dec 28, 2004·0 cites·1 claims
- 2528US2010310591A1Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZAHUMPHREYS ROBERT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Humphreys files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →